![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
REDUCED INCIDENCE OF HEPATOCELLULAR CARCINOMA IN HIV/HBV-COINFECTED PATIENTS RECEIVING TENOFOVIR
|
|
|
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
G. Wandeler, D. Kraus, M. Egger, E. Bernasconi, D. Braun, M. Battegay, A. Calmy, M. Cavassini, P. Schmid, H. Furrer, A. Rauch and the Swiss HIV Cohort Study
![EASL1.gif](../images/042114/042114-13/EASL1.gif)
![EASL2.gif](../images/042114/042114-13/EASL2.gif)
![EASL3.gif](../images/042114/042114-13/EASL3.gif)
![EASL4.gif](../images/042114/042114-13/EASL4.gif)
![EASL5.gif](../images/042114/042114-13/EASL5.gif)
![EASL6.gif](../images/042114/042114-13/EASL6.gif)
![EASL7.gif](../images/042114/042114-13/EASL7.gif)
![EASL8.gif](../images/042114/042114-13/EASL8.gif)
![EASL9.gif](../images/042114/042114-13/EASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|